Carfilzomib (Kryprolis) for multiple myeloma

Med Lett Drugs Ther. 2012 Dec 24;54(1406):103-4.
No abstract available

Publication types

  • Review

MeSH terms

  • Boronic Acids / therapeutic use
  • Bortezomib
  • Clinical Trials as Topic
  • Drug Approval
  • Drug Resistance, Neoplasm
  • Humans
  • Multiple Myeloma / drug therapy*
  • Oligopeptides / administration & dosage
  • Oligopeptides / adverse effects
  • Oligopeptides / economics
  • Oligopeptides / pharmacology
  • Oligopeptides / therapeutic use*
  • Proteasome Endopeptidase Complex / drug effects
  • Pyrazines / therapeutic use

Substances

  • Boronic Acids
  • Oligopeptides
  • Pyrazines
  • Bortezomib
  • carfilzomib
  • Proteasome Endopeptidase Complex